Nicholas S. Green - Apr 9, 2022 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
President & CEO, Director
Signature
/s/ Stephen Hedberg, by Power of Attorney for Nicholas S. Green
Stock symbol
CDMO
Transactions as of
Apr 9, 2022
Transactions value $
-$54,554
Form type
4
Date filed
4/12/2022, 07:50 PM
Previous filing
Jan 11, 2022
Next filing
Jul 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +5.57K +21.89% 31K Apr 9, 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$54.6K -2.94K -9.47% $18.56 28.1K Apr 11, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -5.57K -2.93% $0.00 185K Apr 9, 2022 Common Stock 5.57K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock.
F2 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.56 to $18.70. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.